Pharmacokinetic and pharmacodynamic bioequivalence of Gan & Lee insulin analogues aspart (rapilin®), lispro (prandilin®) and glargine (basalin®) with <scp>EU</scp> ‐ und <scp>US‐sourced</scp> reference insulins - Concepedia

Concepedia

Publication | Closed Access

Pharmacokinetic and pharmacodynamic bioequivalence of Gan & Lee insulin analogues aspart (rapilin®), lispro (prandilin®) and glargine (basalin®) with <scp>EU</scp> ‐ und <scp>US‐sourced</scp> reference insulins

11

Citations

7

References

2023

Year

Wei Chen, Jia Lu, Leona Plum‐Mörschel, Grit Andersen, Eric Zijlstra, Anshun He, Tian Xie, Longling Li, Chunyue Hao, Zhong‐Ru Gan,

Diabetes Obesity and Metabolism

Abstract

GL-Asp, GL-Lis and GL-Gla are bioequivalent to their EU- and US-reference products.

References

	Year	Citations

Page 1